Loading chat...

AR HB1619

Bill

Official Source

Status

Passed

4/1/2021

Primary Sponsor

Justin Boyd

Click for details

Origin

House of Representatives

93rd General Assembly (2021 Regular)

AI Summary

  • Amends Arkansas Code § 5-64-215(b) to allow limited deletion of controlled substances from Schedule VI
  • Excludes prescription drugs approved by the United States Food and Drug Administration under 21 U.S.C. § 355 from Schedule VI classification
  • Permits the Arkansas secretary to object to the FDA-approved drug exclusion under § 5-64-201
  • Maintains the general prohibition against deleting controlled substances from Schedule VI except as provided in the new subsection (c)

Legislative Description

Concerning The Scheduling Of A Schedule Vi Controlled Substance; And To Provide For The Deletion Of A Controlled Substance From Schedule Vi.

Last Action

Notification that HB1619 is now Act 514

4/1/2021

Committee Referrals

Judiciary3/17/2021
Judiciary3/3/2021

Full Bill Text

No bill text available